Atlas Trials

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Clinical trial NCT03372200 · COMPLETED

Trial details

NCT number
NCT03372200
Sponsor
Mochida Pharmaceutical Company, Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperuricemia With or Without Gout
Start date
2018-01-09
Primary completion
2018-06-04
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.